Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1998 Sep;79(2):F110–F113. doi: 10.1136/fn.79.2.f110

Randomised controlled trial of cisapride in feed intolerance in preterm infants

A Enriquez, S Bolisetty, S Patole, P Garvey, P Campbell
PMCID: PMC1720850  PMID: 9828736

Abstract

AIM—To assess the efficacy of cisapride in reducing the time required to establish enteral feeds in preterm infants.
METHODS—A randomised, double blind, placebo controlled trial was conducted of 34 infants of ⩽ 32 weeks of gestation, assigned to receive either cisapride 0.2 mg/kg/dose four times daily (n=18) or placebo (n=16).
RESULTS—The time taken by the babies to tolerate full enteral feeds was not significantly different between the groups (median 9.5days vs 10 days). There was a significantly lower incidence of large gastric residuals and regurgitation in the treated group compared with the placebo group. The number of episodes of large gastric residuals per infant was also significantly less. No adverse effects were noted.
CONCLUSION—The routine use of cisapride in preterm infants cannot be recommended to decrease the time to establish enteral feeds. Its use may be justified for clincally significant gastric stasis or regurgitation.



Full Text

The Full Text of this article is available as a PDF (83.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berseth C. L. Gastrointestinal motility in the neonate. Clin Perinatol. 1996 Jun;23(2):179–190. [PubMed] [Google Scholar]
  2. Carroccio A., Iacono G., Li Voti G., Montalto G., Cavataio F., Tulone V., Lorello D., Kazmierska I., Acierno C., Notarbartolo A. Gastric emptying in infants with gastroesophageal reflux. Ultrasound evaluation before and after cisapride administration. Scand J Gastroenterol. 1992 Sep;27(9):799–804. doi: 10.3109/00365529209011187. [DOI] [PubMed] [Google Scholar]
  3. Cucchiara S. Cisapride therapy for gastrointestinal disease. J Pediatr Gastroenterol Nutr. 1996 Apr;22(3):259–269. doi: 10.1097/00005176-199604000-00007. [DOI] [PubMed] [Google Scholar]
  4. Cucchiara S., Staiano A., Boccieri A., De Stefano M., Capozzi C., Manzi G., Camerlingo F., Paone F. M. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut. 1990 Jan;31(1):21–25. doi: 10.1136/gut.31.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cucchiara S., Staiano A., Capozzi C., Di Lorenzo C., Boccieri A., Auricchio S. Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child. 1987 May;62(5):454–457. doi: 10.1136/adc.62.5.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Di Lorenzo C., Reddy S. N., Villanueva-Meyer J., Mena I., Martin S., Hyman P. E. Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial. Gastroenterology. 1991 Dec;101(6):1564–1570. doi: 10.1016/0016-5085(91)90393-y. [DOI] [PubMed] [Google Scholar]
  7. Hyman P. E., Di Lorenzo C., McAdams L., Flores A. F., Tomomasa T., Garvey T. Q., 3rd Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. Am J Gastroenterol. 1993 Jun;88(6):832–836. [PubMed] [Google Scholar]
  8. Janssens G., Melis K., Vaerenberg M. Long-term use of cisapride (prepulsid) in premature neonates of less than 34 weeks gestational age. J Pediatr Gastroenterol Nutr. 1990 Oct;11(3):420–422. [PubMed] [Google Scholar]
  9. Krevsky B., Malmud L. S., Maurer A. H., Somers M. B., Siegel J. A., Fisher R. S. The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther. 1987 Aug;1(4):293–304. doi: 10.1111/j.1365-2036.1987.tb00629.x. [DOI] [PubMed] [Google Scholar]
  10. Lewin M. B., Bryant R. M., Fenrich A. L., Grifka R. G. Cisapride-induced long QT interval. J Pediatr. 1996 Feb;128(2):279–281. doi: 10.1016/s0022-3476(96)70409-2. [DOI] [PubMed] [Google Scholar]
  11. Lupoglazoff J. M., Bedu A., Faure C., Denjoy I., Casasoprana A., Cézard J. P., Aujard Y. Allongement de l'espace QT sous cisapride chez le nouveau-né et le nourrisson. Arch Pediatr. 1997 Jun;4(6):509–514. doi: 10.1016/s0929-693x(97)87568-9. [DOI] [PubMed] [Google Scholar]
  12. Maddern G. J., Jamieson G. G., Myers J. C., Collins P. J. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease. Gut. 1991 May;32(5):470–474. doi: 10.1136/gut.32.5.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murray R. D., Li B. U., McClung H. J., Heitlinger L., Rehm D. Cisapride for intractable constipation in children: observations from an open trial. J Pediatr Gastroenterol Nutr. 1990 Nov;11(4):503–508. doi: 10.1097/00005176-199011000-00010. [DOI] [PubMed] [Google Scholar]
  14. Neu J., Koldovsky O. Nutrient absorption in the preterm neonate. Clin Perinatol. 1996 Jun;23(2):229–243. [PubMed] [Google Scholar]
  15. Newell S. J., Booth I. W., Morgan M. E., Durbin G. M., McNeish A. S. Gastro-oesophageal reflux in preterm infants. Arch Dis Child. 1989 Jun;64(6):780–786. doi: 10.1136/adc.64.6.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Newell S. J., Sarkar P. K., Durbin G. M., Booth I. W., McNeish A. S. Maturation of the lower oesophageal sphincter in the preterm baby. Gut. 1988 Feb;29(2):167–172. doi: 10.1136/gut.29.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Olsson S., Edwards I. R. Tachycardia during cisapride treatment. BMJ. 1992 Sep 26;305(6856):748–749. doi: 10.1136/bmj.305.6856.748-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Riezzo G., Cucchiara S., Chiloiro M., Minella R., Guerra V., Giorgio I. Gastric emptying and myoelectrical activity in children with nonulcer dyspepsia. Effect of cisapride. Dig Dis Sci. 1995 Jul;40(7):1428–1434. doi: 10.1007/BF02285188. [DOI] [PubMed] [Google Scholar]
  19. Staiano A., Cucchiara S., Andreotti M. R., Minella R., Manzi G. Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci. 1991 Jun;36(6):733–736. doi: 10.1007/BF01311229. [DOI] [PubMed] [Google Scholar]
  20. Valdes L., Champel V., Olivier C., Jonville-Bera A. P., Autret E. Malaise avec allongement de l'espace QT chez un nourrisson de 39 jours traité par cisapride. Arch Pediatr. 1997 Jun;4(6):535–537. doi: 10.1016/s0929-693x(97)87572-0. [DOI] [PubMed] [Google Scholar]
  21. Vandenplas Y., de Roy C., Sacre L. Cisapride decreases prolonged episodes of reflux in infants. J Pediatr Gastroenterol Nutr. 1991 Jan;12(1):44–47. doi: 10.1097/00005176-199101000-00009. [DOI] [PubMed] [Google Scholar]
  22. Wiseman L. R., Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs. 1994 Jan;47(1):116–152. doi: 10.2165/00003495-199447010-00008. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES